Efficacy and Safety of Neoadjuvant Sintilimab in Combination with FLOT Chemotherapy in Patients with HER2-negative Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: an Investigator-Initiated, Single-Arm, Open-Label, Phase II Study.
International Journal of Surgery（2024）
Key words
sintilimab,FLOT,G/GEJ cancer,gastrointestinal neoplasms,neoadjuvant therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined